Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study. - Wikidata - awgldk - TriplyDB

Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study.

Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study.

http://www.wikidata.org/entity/Q33824051

about

Enteric microbiome metabolites correlate with response to simvastatin treatment Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment Lipidomics to Assess Omega 3 Bioactivity From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the future Liquid chromatography quadrupole time-of-flight mass spectrometry characterization of metabolites guided by the METLIN database Metabolomics enables precision medicine: "A White Paper, Community Perspective"Pharmacometabolomics of statin response Pharmacometabolomics reveals that serotonin is implicated in aspirin response variability High-dose simvastatin exhibits enhanced lipid-lowering effects relative to simvastatin/ezetimibe combination therapy Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes.Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology.Metabolomics--a novel window into inflammatory disease.Lipidome and transcriptome profiling of pneumolysin intoxication identifies networks involved in statin-conferred protection of airway epithelial cells.Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions.Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.A lipidomic analysis approach to evaluate the response to cholesterol-lowering food intake Oxylipid Profile of Low-Dose Aspirin Exposure: A Pharmacometabolomics Study Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine.Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging.Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy.Pharmacometabolomics in Early-Phase Clinical Development.Purine pathway implicated in mechanism of resistance to aspirin therapy: pharmacometabolomics-informed pharmacogenomics.Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook.Metabolic and genetic factors modulating subject specific LDL-C responses to plant sterol therapy.Metabolomics and ischaemic heart disease.Pharmacometabonomics and personalized medicine.Getting the right answers: understanding metabolomics challenges.Pharmacometabonomics in humans: a new tool for personalized medicine.Lipidomics in vascular health: current perspectives.Novel Applications of Metabolomics in Personalized Medicine: A Mini-Review.Lipidomics in the Study of Hypertension in Metabolic Syndrome.Gut Microbiota Modulation Attenuated the Hypolipidemic Effect of Simvastatin in High-Fat/Cholesterol-Diet Fed Mice.ALTERED BLOOD SPHINGOLIPIDOMICS AND ELEVATED PLASMA INFLAMMATORY CYTOKINES IN COMBAT VETERANS WITH POST-TRAUMATIC STRESS DISORDER Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics.Pharmacometabolomic signature links simvastatin therapy and insulin resistance.Metabolomics as a tool for personalizing medicine: 2012 update.Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate Metabolomics and Its Role in the Study of Mammalian Systems A Metabolomics Approach to Pharmacotherapy Personalization

P2860

Q21135141-4600F2D9-D8CA-4477-AD3F-EFFF5D542E78 Q21561017-FA5B83CA-36A3-4296-8C97-791B2D62752B Q26786927-E3AE7881-96C2-4051-A2BB-22E525D1AC25 Q28067029-1A858971-B6B4-4494-8006-0DEB866017EA Q28074451-98BEEA4D-9074-4206-BA3B-B2ECED94D964 Q28686521-09EDAE93-3565-4D84-983A-E83E1006D6C5 Q28831476-EDF583D5-6FEB-43CA-B840-750953D72088 Q33746373-9EAC78FB-6F9F-4711-A8B1-29DE583E1CA6 Q33994559-8EAEB7BA-2338-44CA-873A-C3A7B6033678 Q34729515-BE70AE31-D84A-4988-B194-49EE26A31031 Q35004985-1210BF7F-DA3D-4D85-B3EC-34CCD4F9BE1E Q35032056-8D9127B1-6C82-4CDE-977F-31B4E511633D Q35112344-10E8B8B6-DC81-41AD-BCA9-DDB6DB528D70 Q35663656-1FA24992-A70F-4205-9D5E-361B9E555363 Q36112019-5F2C056E-D245-4F82-AC09-CCFE4A685891 Q36142593-CE4BA184-B07E-4A7B-BFA3-C406354F158D Q36301541-46F59981-26A8-4427-98D2-07344A72A146 Q36835930-818659AD-16A7-41C8-A898-B4B9FE1DC328 Q37078812-0F9BC9E8-FB19-40EC-B4D8-0FBC5AB914B9 Q37485378-47B90945-DC74-422E-A47C-9A0250411DC5 Q37512208-C530F91D-118D-42B6-951B-50D77076ED61 Q37701143-61DCEA2F-984B-4EE5-9E45-B9AD9535B1CD Q37726989-EC8EEEE5-C986-4516-969A-F0B45BD2108F Q37943853-6D1541D2-E286-4C42-B203-73C54ED64A03 Q38002920-F396C867-DE11-45DB-8D70-8D43DBED2583 Q38060209-D04623D2-908B-4E8F-AEE3-6CB64FBDE572 Q38124254-563C89DA-3F39-4CF3-8B77-FFFEE81809DF Q38263691-C4301856-7D54-425B-92F5-20068E19A8B2 Q38452107-241D24FF-D49D-4894-AB98-7B5154097C67 Q38537535-CAEF8C25-29BB-45BD-9457-039628D581E9 Q38658253-4160538D-63EC-434D-9423-287AACDE79AE Q39123802-0D9A9E37-9577-4B28-9529-2A47F073DF47 Q40257529-7D24BC48-253D-4645-B02D-C3A845C30A50 Q41853330-06CA5D8D-0E72-4549-8336-12D6F7C55448 Q49299846-AABC2D7C-32B1-4330-87C2-0098E066C192 Q53755580-0F0EB360-E5AE-4A13-92E8-0EBE00265286 Q54257582-6690AB1F-B51B-4C6B-AB12-1F54C3A6B4D7 Q57112884-D070ECB0-36F0-47DC-9007-F3E71FCBA80C Q57797380-9D6ACCDF-361C-4A83-A5C2-DA88CA4FF557 Q58762484-78A4AE27-FAC9-4332-82C6-D55A306F2192

P2860

Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study.

http://www.wikidata.org/entity/Q33824051

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Lipidomic analysis of variatio ...... ol and Pharmacogenetics Study.

@ast

Lipidomic analysis of variatio ...... ol and Pharmacogenetics Study.

@en

type

label

Lipidomic analysis of variatio ...... ol and Pharmacogenetics Study.

@ast

Lipidomic analysis of variatio ...... ol and Pharmacogenetics Study.

@en

prefLabel

Lipidomic analysis of variatio ...... ol and Pharmacogenetics Study.

@ast

Lipidomic analysis of variatio ...... ol and Pharmacogenetics Study.

@en

P1433

Q33824051-5153B70A-731F-4214-82DA-CE66984AEC2C

P1476

Q33824051-E1CDD06B-7472-4892-A7AE-559D9E83D9BE

P2093

Q33824051-12C2DFA4-9FB4-4C26-9270-D8CDB066108B

Q33824051-5BD3DC9B-FEA8-4338-8910-08E96264AA85

Q33824051-705431AD-EAEC-4968-B1AA-6728BC0815F8

Q33824051-7059401F-A4A6-49A5-B3B4-8533406C2610

Q33824051-7E6B2B76-9E9E-45C0-86FE-B77A98F4FA40

Q33824051-AC8D3708-1C4C-4159-8335-085176B76043

P2860

Q33824051-03E9DFDA-4A50-49C8-9910-0342CF0236DB

Q33824051-09A623EF-4131-4B04-AA7D-EA3B65F3A375

Q33824051-13AFDD3F-30FC-418C-9496-A629E464A711

Q33824051-16F619A6-ED58-4F55-A365-0D2A773F2C3A

Q33824051-24C0D27D-0683-4A76-8FE9-33F789B76502

Q33824051-33FF21D9-673F-47BD-9205-6D42FC51AE98

Q33824051-34A0730B-03C1-42AE-B784-4C7227D722B8

Q33824051-44840368-5882-424B-BD8E-00D61B8E05CE

Q33824051-56F33AAA-534F-40AC-9C87-0BCC1503009B

Q33824051-5D97D6E3-87BE-43AB-A8D4-3FC900097C56

P2888

Q33824051-8889E24A-B6AD-4794-995E-942EB1A86EAA

P304

Q33824051-833EE6B3-D14C-48A5-9947-D8434DEA7E53

P31

Q33824051-7AA3E6F8-61EB-4917-925A-D59143AFF730

P356

Q33824051-CBE74ED9-50FF-4F44-B595-8A0F87AE1E1A

P433

Q33824051-95A495FD-0B7C-4D7F-9F44-305196732B9C

P478

Q33824051-326D6602-BEE7-4658-9623-7AFA7A8CA37D

P50

Q33824051-10442AB1-3E03-4A48-8F0E-4C6EA68B15FD

Q33824051-D250E9AA-A87F-4BEF-8B8F-AC754074F004

P577

Q33824051-9288109A-966D-4BEB-AF6D-A8A9609C686D

P5875

Q33824051-FC8907FE-B83B-4E7E-B1E9-7075A9E6BAA8

P6179

Q33824051-D7465551-F9A9-4400-A0D7-F7AF8447139E

P698

Q33824051-F3119DF4-A786-42FE-860A-47E8E222FB68

P932

Q33824051-2306E4B3-C869-4534-AC71-DB265F1DBC39

P356

S11306-010-0207-X

P1433

P1476

Lipidomic analysis of variatio ...... rol and Pharmacogenetics Study

@en

P2093

Hongjie Zhu

http://www.w3.org/2001/XMLSchema#string

Michelle M Wiest

http://www.w3.org/2001/XMLSchema#string

Ronald M Krauss

http://www.w3.org/2001/XMLSchema#string

Steven M Watkins

http://www.w3.org/2001/XMLSchema#string

Uyen Thao Nguyen

http://www.w3.org/2001/XMLSchema#string

Zhao-Bang Zeng

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical significance for genomewide studies

A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later.

Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis.

Beneficial effects of statins in coronary artery disease--beyond lowering cholesterol.

United States Cholesterol Guidelines 2001: expanded scope of intensive low-density lipoprotein-lowering therapy.

Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers.

P2888

s11306-010-0207-x

P304

191-201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11306-010-0207-X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Rima Kaddurah-Daouk

Rebecca Baillie

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44576303

http://www.w3.org/2001/XMLSchema#string

P6179

1025037285

http://www.w3.org/2001/XMLSchema#string

P698

20445760

http://www.w3.org/2001/XMLSchema#string

P932

2862962

http://www.w3.org/2001/XMLSchema#string